Delivery Order SPE2DB20D1100-SPE2DB24FA6K8
- Not listed
- This federal contract award, valued at $1,572.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,145.44 firm fixed price delivery order is for the provision of 4564020469 - XEOMIN 100 UNIT VIALS to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for XEOMIN 200 UNIT VIALS, with a ceiling value of $15,727.50 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,145.50 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564421570 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,155.52, is for the delivery of XEOMIN 200 UNIT VIALS, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,145.44 firm fixed price delivery order is for the supply of 4,563,594,671 XEOMIN 100 unit vials, with a completion date of February 28, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,704.88 firm fixed-price delivery order is for the supply of 4567346377 XEOMIN 200 UNIT VIALS, with a period of performance through March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $44,036.16 Firm Fixed Price Delivery Order contract is for the provision of 4,564,421,571 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract does not have a set-aside designation and has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is to provide 4,564,696.31 units of the pharmaceutical product XEOMIN 100 UT VIAL 1S to the U.S. government. The $52,424.00 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense, and has a completion date of June 13, 2024. The contract is a delivery order issued under...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XEOMIN 100 unit vials. The $10,484.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA6K8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price of $8,550.00 and a period of performance through March 29, 2024. It involves the supply of XEOMIN 50 unit vials, a pharmaceutical product, to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen Drug Corp is the prime contractor on this award, and no set-aside designation was used. Additionally, Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 with a performance period through December 31, 2025, which serves as the primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 3/8/24 |